Jump to content

Bromoantimonates

Add links
From Wikipedia, the free encyclopedia

Bromoantimonates are compounds containing anions composed of bromide (Br−) and antimony (Sb). They can be considered as double bromides, metallohalides or halometallates. They are in the category of halopnictates. Related compounds include the bromobismuthates, iodoantimonates, bromophosphates, and bromoarsenates.

Some examples of bromoantimonates

[edit]

Bromoantimonates can have antimony in one of two oxidation states, either +3 or +5. These are designated by bromoantimonate(III) or bromoantimonate(V). Although antimony tribromide is known, SbBr5 on its own does not exist, despite the existence of SbBr−6.[1] Compounds containing both Sb(III) and Sb(V) are mixed valence compounds. The antimony can be linked into chains, (which are called one-dimensional as it is like a line), or in pairs as Sb2 or singly as Sb (which are called zero-dimensional, as the anions are just point-like).

Tetrabromoantimonate(III) (SbBr4−) has single antimony atoms in each anion.[2]

SbBr52− contains infinite chains of SbBr6 octahedra linked by corners.[3]

Hexabromoantimonate(III) SbBr63− also exists, forming zero-dimensional compounds.[4]

Nonabromodiantimonate(III) Sb2Br93− has a pair of octahedra of SbBr6 sharing a face. The angles formed by shared bromine at the antimony are reduced from the theoretical 90° to about 80°.[5]

Hexabromoantimonate(V) SbBr6− exists in equilibrium with SbBr4− and Br2 but real +5 oxidation state bromoantimonates exist even if SbBr5 is unstable and does not exist.[6][7][8]

Intersecting classes are nonahalogenodiantimon(III)ates. Hexahaloantimonate(III) ions (SbX63−) can include chlorine or iodine as well as bromine.[9]

Related classes include halogeno-oxydiantimon(III)ates, and pentabromothio-diantimonates.[10] Bromo-phenylantimonates(V) (C6H5SbBr5) have a phenyl group substituting for one bromine atom.[11] Chlorobromoantimonates(V) have some chlorine instead of bromine.[12]

The antimonide bromides are distinct as they do not have a bond between antimony and bromine. Tetrabromostibonium(V) contains cations (SbBr+4) rather than anions.[13]

Preparation

[edit]

Bromoantimonates can be made using a water solution of antimony tribromide, hydrobromic acid, and an amine. Alternately antimony trioxide can be used. Variants can be made without using water, and heating the antimony tribromide with an amine hydrobromide.[14]

Some properties

[edit]

Most of the bromoantimonate salts are yellow or orange.[15]

For SbBr−4 there are absorption bands at 224, 300, 245 and 216 nm. SbBr3−6 has absorption bands centred on 359, 311, and 266 nm.[16]

Many alkylammonium salts are known. These can have different solid phases at different temperatures, as the alkyl group varies in disorder. Those with longer alkyl chains have a greater number of solid state phases.[17]

Methyl ammonium compounds are ferroelectric.[17]

The infrared spectrum includes wavenumbers (ν/c) of 110 to 130 cm−1 for the bridging bromine in Sb2Br9 and 135 to 220 cm−1 for non-bridging bromine to antimony stretching.[18]

Bond lengths in SbBr6− are 2.65 and 2.56 Å. In SbBr63− the lengths are greater, from 2.787 to 2.713 Å.[19]

Use

[edit]

Bromoantimonates are researched for use in photovoltaics,[20] X-ray detectors,[21] and LEDs.[22]

List

[edit]
Name (full or part) Formula System Space group Unit cell (Å) Volume Density Notes Ref
ammonium [H4N]2SbBr6 tetragonal I41/amd a=10.66 c=21.52 black; Sb(III) and Sb(V) [7][23]
ammonium (NH4)3Sb2Br9 inefficient photovoltaic; soluble in ethanol [24]
ammonium (NH4)7Sb3Br16 [25]
guanidinium [C(NH2)3]SbBr6 black; Sb(V) [26]
guanidinium [C(NH2)3]3Sb2Br9 monoclinic C2/c a = 15.695 b = 9.039 c = 18.364 β = 96.94° Z=4 @143K; phase transition 435/450 K [27][28]
Tris(N,N,N',N'-tetramethylguanidinium) nonabromodiantimonate(III) [NH2C(N(CH3)2)2]3[Sb2Br9] triclinic P1 a 10.9824 b 12.1782 c 15.0405 α 71.064° β 88.199° γ 85.024° [29]
methylammonium (CH3NH3)3SbBr6 monoclinic P21/c a=13.577 b=8.254 c=21.665 β=134.05° Z=4 [30]
methylammonium bromoantimonate(III) (CH3NH3)3Sb2Br9 P3m1 a=8.188 c=9.927 Z=1 3.049 yellow [31][32]
dimethyl ammonium [(CH3)2NH2]3SbBr6 [30]
tris (dimethylammonium) nonabromodiantimonate(III) [(CH3)2NH2]3Sb2Br9 monoclinic P21/a a = 14.612 b = 9.228 c = 10.005 β = 94.91° Z = 2 [33]
[NH2(CH3)2]3Sb2Br9
tris(Trimethylammonium) nonabromodiantimonate(III) [(CH3)3NH]3Sb2Br9 orthorhomic a 11.40 b 10.31 c 12.91 [34]
tetramethylammonium [NMe4]3[Sb2Br9] hexagonal P63/mmc a=9.499 c=22.225 Z=2 crimson red [35][36]
tetramethylammonium [NMe4]3[Sb2Br9]•Br2 hexagonal P63/mmc a=9.585 c=22.667 Z=2 [37]
tetramethylammonium [(CH3)4N]3Sb3Br9•Br2 hexagonal P63/mmc a=9.5850 c=22.667 Z=2 2.48 red; yellow-orange when cold [38]
tetramethylammonium [(CH3)4N]3Sb2Br9•I2 triclinic P1 a=9.4869 b=9.5409 c=22.4906 α=92.058° β=90.933° γ=118.386° Z=2 1788.5 dark [39]
ethylammonium (C2H5NH3)2[SbBr5] orthorhombic Cmca a= 7.815 b=22.301 c=18.100 Z=8 3154.5 2.584 at 298K; yellow; phase transition at 158.5K; decompose >450K [15][30]
ethylammonium (C2H5NH3)2[SbBr5] orthorhombic Pbca a=7.684 b=22.413 c=17.780 Z=8 3062.1 2.661 at 90K; yellow [15]
ethylammonium (C2H5NH3)2[SbBr7] [40]
diethylammonium ([C2H5]2NH2)3SbBr6 hexagonal R3c a=15.155 c=20.085 Z=6 dissolves in acetone [41][34]
tetraethylammonium [(C2H5)4N]2SbBr6 very dark reddish brown [7]
tetraethylammonium [(C2H5)4N]3Sb2Br9 hexagonal P6322 a=10.3 c=24.4 Z=2 2242 2.02 yellow [42][43]
tetraethylammonium hexabromoantimonate(V) [(C2H5)4N]SbBr6 tetragonal I41md a=8.7008 c=24.797 Z=4 1877.3 2.59 dark red-brown [44][45]
n-propylammonium (n-C3H7NH3)2SbBr5 orthorhombic ? a =7.884 b=14.516 c=15.913 Z=4 1821.1 2.33 4 phase transitions: 189K, 165/163, 137/154 [46][30][47]
di-n-propylammonium [(n-C3H7)2NH2]3SbBr6 hexagonal R3c a=13.649 c=31.548 Z=6 dissolves in acetone [41]
tris(Tri-n-propylammonium) nonabromodiantimonate(III) [(n-C3H7)3NH]3Sb2Br9 orthorhombic ? a 12.91 b 14.51 c 20.0 [34]
bis(Isopropylammonium) pentabromoantimonate(III) [(i-C3H7)2NH2]2SbBr5 orthorhombic a 14.99 b 16.687 c 21.72 [34]
tetrapropylammonium [(C3H7)4N][SbBr4] orthorhombic Pbca a=15.566 b=13.822 c=19.574 Z=8 4211.5 yellow [48]
isopropylammonium [(CH3)2CHNH3]2SbBr5 orthorhombic a=12.013 b =12.134 c=12.525 phase transition at 171K, 180 K [49]
isopropylammonium [(CH3)2CHNH3]2SbBr5 monoclinic [50]
tris(N-ethyl-N,N-dipropylpropan-1-aminium) tetrakis(μ-bromo)-octabromo-tri-antimony (Et(n-Pr)3N)3[Sb3Br12] triclinic P1 a 10.6469 b 14.8847 c 18.3714 α 86.082° β 85.502° γ 84.116° [51]
isobutyl (i-C4H9NH3)2SbBr5 [52]
ethanediammonium [NH3(CH2)2NH3]5(Sb2Br11)2·4H2O monoclinic P21/a a = 14.346 b = 13.206 c = 17.027 β = 113.05° Z = 2 2.941 [53]
N,N,N',N'-tetramethylethylendiammonium [tetrabromidoantimonate(III)-μ-bromido] hemihydrate (C6H18N2)2[Sb2Br10]·H2O orthorhombic Pbca a = 18.0860 b = 19.1755 c = 19.4619 Z=8 6749.5 2.553 yellow [54]
anilinium (C6H5NH3)2SbBr5 orthorhombic Pbca a = 19.704 b = 7.914 c = 25.556, Z = 8 3985 2.365 yellow green; insoluble water [3]
dihydrazinium pentabromoantimonite (N2H5)2SbBr5 yellow [25]
Trihydrazinium nonabromodiantimonite (N2H5)3Sb2Br9 yellow [25]
Undecahydrazinium heptadecabromodiantimonite (N2H5)11Sb2Br17 yellow; melt 165° [25]
Decahydrazinium nonadecabromotriantimonite (N2H5)10Sb3Br19 yellow [25]
triazolinium (C2H4N3)2[SbBr5]·(C2H4N3)Br orthorhombic P212121 a=8.6087 b=11.7985 c=20.5457 [55]
1,2,4-triazolium (C2N3H4)3[SbBr6] tetragonal P42/m a=11.149 c=8.318 Z=2 1033.9 2.606 @320K [56]
1,2,4-triazolium (C2N3H4)3[SbBr6] monoclinic a=15.699 b=16.294 c=15.018 β = 90.41 Z=8 4097 2.631 @293K
allylammonium (C3H5NH3)3SbBr6 monoclinic C2/m 4 phases [57]
butylammonium [n-C4H9NH3]2•[SbBr5] orthorhombic Pnma a=16.845 b=54.899 c=15.697 340K deep yellow; 3 phases [58]
butylammonium [n-C4H9NH3]2•[SbBr5] monoclinic P2/m a=15.597, b=62.854, c=16.771 β=92.05° 300K [58]
tris(n-Butylammonium) hexabromo-antimony(III) [n-C4H9NH3]3•[SbBr6] a 11.47 b 15.07 c 18.57 [34]
di-n-butylammonium [(n-C4H9)2NH2]3•[SbBr6] monoclinic P21/c a 13.03 b 13.51 c 18.94 β 94.0° [30][34]
tetra-n-butylammonium hexa-bromoantimonate(V) [(n-C4H9)4N]•[SbBr6] [44]
pentylammonium [n-C5H11NH3]2•[SbBr5] orthorhombic Pna21 a=17.0105 b=32.875 c=7.8882 298K; 3 phases transitions at 388K 224K [17]
pentylammonium [n-C5H11NH3]2•[SbBr5] orthorhombic P212121 a=16.9234 b=32.3689 c=7.7418 86K [17]
2,2-difluoroethylammonium [C2H6F2N]3SbBr6 monoclinic P121/n1 a=8.0145 b=12.1192 c=21.2967 β=91.686 Z=4 2067.6 2.722 yellow [59]
N-ethyl-1,3-propanediammonium [C5N2H16]2SbBr5 monoclinic P21/c a=21.426 b=7.889 c=19.96 β=116.79° Z=8 3012 [60]
N-ethyl-1,3-propanediammonium [C5N2H16]2SbBr5 orthorhombic Pnma a=19.23 b=7.894 c=10.118 Z=4 1536 yellow [60]
bis(N,N-diethylethylendiammonium) decabromodiantimoinate(III) [C6H18N2]2Sb2Br10 monoclinic P21/c a = 10.7309 b = 10.5842 c = 14.5551 β = 96.962° Z = 4. yellow [61]
1,5-pentanediammonium pentabromoantimonate (III) [NH3(CH2)5NH3]SbBr5 orthorhombic P212121 a 7.964 b 13.9424 c 14.065 @293K [62]
1,5-pentanediammonium pentabromoantimonate (III) [NH3(CH2)5NH3]SbBr5 orthorhombic Pnma a 14.04 b 8.04 c 13.97 @393K [62]
Ethyldimethylphenylammonium [EtMe2PhN]3[Sb2Br9] orthorhombic Pnma a = 35.620 b = 9.954 c = 12.761 Z = 4 [63]
Tris(N,N-dimethylanilinium) tri--bromido-bis[tribromidoantimonate(III)] (C8H12N)3[Sb2Br9] triclinic P1 a 9.7857(b 13.7658(c 17.0297(α 66.581( β 78.689( γ 72.601( Z=2 [64]
[CH3SC(NH2)2]2SbBr5 11.4258 b=8.9079 c=17.3627 β=92.225 Z=4 1765.8 2.647 [65]
cyclopropylammonium [C3H8N]2SbBr5 monoclinic P21/c a=11.8937 b=19.0986 c=7.8047 β = 108.908° 1168.0 2.525 270K [66]
cyclopropylammonium [C3H8N]2SbBr5 orthorhombic Pnca a=22.5314 b=18.9885 c=7.8845 Z=8 2336.0 2.511 300K [66]
cyclopropylammonium [C3H8N]2SbBr5 orthorhombic Bbcm a=22.4485 b=18.9653 c=7.9488 Z=8 2256 2.503 325K; band gap 2.41 eV; phase changes at 290 K and = 315 K [66]
Benzeneethanammonium (C8NH12)2SbBr5 yellow [67]
phenylmethylammonium (C6H5CH2NH3)3SbBr6 monoclinic P21/c a 15.2246 b 8.0632 c 24.3042 β 100.005° Z=4 2938.2 2.093 yellow [68]
(R)-(−)-1-cyclohexylethylammonium (R-CHEAH)Sb3Br10 monoclinic P21 a=12.76938 b=30.1777 c=13.2336 β=90.818 [69]
Pyrrolidinium [C4H9N]2SbBr8 monoclinic a=31.4 b=9.71 c=15.0 β=99.0° Z=8 4517 2.50 black [70]
2-Pyrolidonium [C4H6ONH]2SbBr8 black; orange red when cold [70]
N-methylpyrrolidinium [C4H9NCH3]3Sb2Br9 trigonal R3c a=15.6943 c=15.6943 Z=6 5018.8 2.424 yellow @293K [71]
N-methylpyrrolidinium [C4H9NCH3]3Sb2Br9 trigonal R3c a=15.9951 c=23.1124 Z=5 5120.9 2.376 @335K [71]
N-methylpiperidine (C6H14N)3Sb3Br12 monoclinic P21/n a=10.9372 b=21.928 c=17.598 β=90.796° Z=4 4219.5 [72]
Piperidinium [C5H11N]2SbBr8 monoclinic a=28.8 b=19.8 c=18.7 β=116.28 Z=16 9561 2.58 black [70]
Piperazine-1,4-diium (C4H12N2)[SbBr5]·H2O monoclinic P21/n a=9.9162 b=14.4090 c=10.3898 β=99.432 Z=4 1464.45 2.846 [73]
Morpholinium [NH2(C2H4)2O]SbBr4 orthorhombic Pbca a=12.273 b=8.397 c=23.276 Z=8 2399 2.933 yellow [74]
Morpholinium [NH2(C2H4)2O]2[SbBr5] orthorhombic P212121 a 9.274 b 10.325 c 18.472 Z=4 1768.8 2.620 yellow; piezoelectric [75]
Morpholinium [C4H9ONH]2SbBr8 orthorhombic Pna21 a=28.01 b=8.31 c=10.02 Z=4 2332 2.64 black; red when cold [70]
Pyridinium (C5H5NH)SbBr4 triclinic P1 @116K [76]
Pyridinium (C5H5NH)SbBr4 monoclinic C2/c a=11.825 b=13.048 c=7.798 β=93.87° Z=4 2.922 @297K [57][76]
Pyridinium (C5H5NH)6SbIIISbV3Br24 orthorhombic CmC21 a=17.51 b=23.77 c=16.46 Z=4 6851 2.80 black [70]
benzylammonium (C6H5CH2NH3)2SbBr5 monoclinic P21/a a=8.0254 b=19.5087 c=14.5079 β=107.451 Z=4 2166.89 2.261 yellow [77]
1-methylpyridinium (1−CH3C5H4NH)SbBr4 monoclinic P21/c a=12.73 b=13.54 c=7.59 β=107.3 Z=4 1250 2.85 pale yellow [78]
bis(1-methylpyridin-1-ium) hexabromo-antimony tribromide (1−CH3C5H4NH)2SbBr6•Br3 triclinic P1 a 7.4567 b 9.4488 c 9.6777 α 68.629° β 89.848° γ 73.002° 1029.2 [79] (1)
2-methylpyridinium (2−CH3C5H4NH)SbBr4 monoclinic P21/c a=12.84 b=13.31 c=7.65 β=106.6 Z=4 1252 2.84 pale yellow [78]
3-methylpyridinium (3−CH3C5H4NH)SbBr4 monoclinic P21/c a=12.51 b=13.64 c=7.72 β=106.9 Z=4 1260 2.76 pale yellow [78]
bis(2-bromo-5-methylpyridinium) hexabromoantimonate tribromide (2-Br-5-MePy)2[SbBr6](Br3) monoclinic Im a 8.4041 b 13.341 c 12.237 β 95.731° [80]
3-carboxylpyridinium (3−COOHC5H4NH)2SbBr5 monoclinic C2/c a=14.10 b=19.43 c=8.01 β=98.6° Z=4 2169 2.36 lemon yellow [78]
4-methylpyridinium (4−CH3C5H4NH)SbBr4 monoclinic P21/c a 12.011 b 13.581 c 7.7637 β 90.341° [81]
4-methylpyridinium (4−CH3C5H4NH)2SbBr5 triclinic P1 a=10.66 b=10.86 c=9.30 α=108.8° β=97.7° γ=99.2° Z=2 985 2.39 yellow needles [57][78][82]
4-methylpyridinium (4−CH3C5H4NH)3Sb2Br9•I2 monoclinic P21 a=8.3290 b=23.5510 c=9.4722 β=104.388 Z=2 1799.7 [39]
4-methylpyridinium (4−CH3C5H4NH)2SbBr5•I2 monoclinic P21/n a=7.5955 b=14.6757 c=9.5902 β=91.607 Z=2 2182.85 [39]
4-methylpyridinium (4-C6H7NH)2SbVBr9 monoclinic C2/m a=18.39 b=7.440 c=9.84 β=113.14° 2.760 red [83]
α-picolinium (2−CH3C5H4NH)2SbBr9 triclinic P1 a 9.249 b 9.750 c 7.645 α 90.07° β 107.46° γ 70.52° Z=2 2.77 black; orange at −174° [70][84]
β-picolinium (3−CH3C5H4NH)2SbBr9 monoclinic Z=2 2.74 black; orange at −174° [70]
γ-picolinium (4−CH3C5H4NH)2SbBr9 monoclinic Z=2 2.77 black; red at −174° [70]
1-fluoropyridinium (1-FPy)3[Sb2Br9] monoclinic C2/c a=21.85 b=21.15 c=13.85 β=104.6° Z=8 6179 2.70 deep yellow [78]
1-bromopyridinium ? monoclinic C2/c a=11.83 b=13.03 c=7.70 β=93.9° 1183 2.4 light orange [78]
2-chloropyridinium (2-ClPyH)2SbBr5 monoclinic P21/a a=10.64 b=15.87 c=5.88 β=105.3° Z=2 957 2.60 orange [78]
2-chloropyridinium (2-ClPyH)SbBr6 monoclinic P21/c a=13.0770 b=7.3498 c=16.5301 β=112.117° Sb(V) [85]
2-bromopyridinium (2-BrPyH)2SbBr5 monoclinic P21/a a=10.53 b=16.17 c=5.89 β=104.8° Z=2 989 2.82 red [78]
2-bromopyridinium (2-BrPyH)SbBr6 monoclinic P21/c a=13.111 b=7.3787 c=16.555 β=111.179° Sb(V) [85]
bis(2-iodopyridinium) hexabromoantimonate tribromide (2-IPyH)2[SbBr6](Br3) monoclinic P21/n a 8.1800 b 12.9394 c 12.5865 β 105.412° [80]
3-chloropyridinium (3-ClPyH)SbBr6 orthorhombic Pca21 a=16.6414 b=7.3471 c=24.2543 Z=8 2965.5 cherry-red [86]
3-bromopyridinium (3-BrPyH)2SbBr5 monoclinic P21/c a=18.37 b=11.98 c=9.35 β=102.5° Z=4 2009 2.77 pale yellow [78]
3-bromopyridinium (3-BrPyH)SbBr6 orthorhombic Pca21 cherry-red [86]
3-iodopyridinium (3-IPyH)2SbBr5 monoclinic P21/c a=17.99 b=12.31 c=9.35 β=91.5° Z=4 2070 2.99 pale yellow [78]
4-bromopyridinium pentabromoantimonate(III) (4-BrC5H4NH)2SbBr5 triclinic P1 a = 9.186 b = 10.622 c = 10.703 α = 99.665° β = 97.393° γ = 108.539° Z = 2 [87]
bis(4-bromopyridinium) hexabromoantimonate tribromide (4-BrPyH)2[SbBr6](Br3) monoclinic P21/c a 7.3255 b 20.667 c 16.5665 β 95.627° [80]
2,6-dichloropyridinium (2,6-ClPyH)[SbBr4] monoclinic P2/m a=10.45 b=10.76 c=13.45 β=110.2 Z=4 1491 2.76 pale yellow [78]
2,6-dibromopyridinium (2,6-BrPyH)3[SbBr6](Br3) · 2H2O monoclinic C2/c a=32.8242 b=9.6155 c=14.7877 β=101.732° [88]
3,5-dichloropyridinium (3,5-ClPyH)2[SbBr5] orthorhombic Pbca a=21,77 b=8.14 c=24.38 Z=8 4320 2.52 deep yellow [78]
N-ethylpyridinium EtPySbBr6 [89]
N-propylpyridinium 1-n-PrPySbBr6 monoclinic P21/n a=7.3687 b=16.4706 c=13.8620 β=97.054 Z=4 1669.65 [80] (1)
N-butylpyridinium 1-n=BuPySbBr6 orthorhombic P212121 a=7.4277 b=14.1293 c=16.7699 Z=4 1760.0 [80] (2)
2-aminopyridinium [2-NH2C5H4NH][SbBr4] monoclinic P21/c a 12.484 b 13.106 c 7.492 β 105.84° Z=4 1179.1 3.022 @100K phase transition at 396/412K [90]
4-aminopyridinium (4-NH2C5H4NH)SbBr4 monoclinic P21/c a 11.548 b 14.029 c 7.432 β 93.19° @220K [91]
tetrakis(2,2'-bipyridin-1-ium) tetrakis(μ-bromo)-hexadecabromo-tetra-antimony (2,2′-bipyH)4[Sb4Br20] monoclinic P21/c a 14.5026 b 14.6945 c 16.5497 β 109.991° [51]
bis(pyridinium)ethane (PyC2){[SbBr6](Br3)} triclinic P1 a=7.3269 b=9.1941 c=9.7994  α=64.474 β=80.207 γ=86.244 Z=1 586.99 cherry-red [92]
1,1′-(1,2-ethanediyl)bis(pyridine) PyC22+SbBr5 triclinic P1 a 10.1060 b 10.2956 c 11.1394 α 105.030° β 101.709° γ 117.233° [93]
1,1′-(1,2-ethanediyl)bis(3,5-dimethylpyridine) 3,5-MePyC22+SbBr5 monoclinic P2/n a 6.2898 b 8.7454 c 20.408 β 90.438° [93]
1,1′-(1,2-ethanediyl)bis(pyridine) (C2Py)2[Sb2Br10] triclinic P1 a 6.1343 b 9.2857 c 17.2041 α 90.331° β 100.259° γ 99.912° [93]
1,1′-(1,2-ethanediyl)bis(pyridine) (C2Py)2[Sb2Br10] monoclinic C2/c a 19.6880 b 10.0152 c 20.8410 β 111.104° [93]
1,1′-(1,2-ethanediyl)bis(3,5-dimethylpyridine) (3,5-MePy){[SbBr4]} monoclinic P21/n a 20.5536 b 7.2974 c 21.2510 β 117.694° [93]
bis(pyridinium)propane (PyC3)2[Sb2Br9][SbBr6] orthorhombic Pmmm a=20.3785 b=15.5018 c=7.4618 Z=2 2357.2 mixed III V valence [92]
bis(pyridinium)butane (PyC4){[SbBr6](Br3)} triclinic P1 a=7.8627 b=9.1285 c=10.1514 α=68.392° β=89.669° γ=72.048° Z=1 639.63 [92]
4-ethylpyridinium (4−CH3CH2C5H4NH)3Sb2Br14 orthorhombic Pna21 Z=4 2.55 black; orange-red at −174° [70]
1,1′-(propane-1,3-diyl)bis(4-methylpyridin)-1-ium (4-MePyC3)2[SbBr6]2[Br5]2 monoclinic P21/n a=7.7157 b=16.1786 c=24.292 β=96.972° Sb(V) [94]
propanediyl-bis(3-methylpyridinium) (3-MePyC3)3[Sb4Br16] monoclinic P21/n a 11.6777 b 42.282 c 16.5504 β 95.618° [95]
1,1'-(ethane-1,2-diyl)bis(3-methylpyridin-1-ium) (3-MePyC2)3[Sb2Br9]2 triclinic P1 a 10.6368 b 10.8059 c 15.4810 α 76.034° β 81.735° γ 83.387° [95]
bis(1,1'-(butane-1,4-diyl)bis(3-methylpyridin-1-ium)) hexakis(μ-bromo)-decabromo-tetra-antimony(iii) (3-MePyC4)3[Sb4Br16] monoclinic P21/n a 14.2410 b 11.2731 c 19.0662 β 110.674° [95]
4,4'-dimethyl-1,1'-butanediylbis(pyridinium) (4-MePyC4)[Sb2Br8] monoclinic P 2/c a 26.313 b 6.4010 c 17.9886 β 109.026° [96]
4,4'-dimethyl-1,1'-butanediylbis(pyridinium) (4-MePyC4)2[Sb4Br16] monoclinic P21/n a 11.4661 b 19.7236 c 12.5217 β 92.726° [96]
1,3,4-trimethylpyridin-1-ium 1,3,4-MePy[SbBr6] triclinic P1 a 8.3195 b 8.9921 c 12.3360 α 86.146° β 76.520° γ 71.872° Sb(V) [97]
1,4-dimethylpyridin-1-ium 1,4-MePy[SbBr6] triclinic P1 a 7.6803 b 8.5900 c 12.6261 α 75.226° β 88.079° γ 79.872° Sb(V) [97]
1,2-dimethylpyridinium (1,2-MePy)2[SbBr6](Br3) monoclinic P21/n a=7.3284 b=10.5875 c=16.7538 β=96.005° Sb(V) [97]
1,3-dimethylpyridinium (1,3-MePy)2[SbBr6](Br3) triclinic P1 a 7.2611 b 9.086 c 11.1895 α 67.617° β 87.457° γ 72.16° [80] (5)
2,4-dimethylpyridinium ? orthorhombic Pmmn a=12.06 b=12.97 c=11.49 1797 2.2 yellow [78]
2,6-dimethylpyridinium (2,6-MePy)3[Sb2Br9] monoclinic P21/c a=12.10 b=15.56 c=21.27 β=115.7 Z=4° 3629 2.36 pale yellow [78]
1-ethyl-3-methylpyridinium (1-Et-3-MePy)2[SbBr6](Br3) triclinic P1 a 7.2472 b 9.4088 c 11.5541 α 69.263° β 81.162° γ 71.303° [80]
4-ethyl-1-methylpyridinium (4-Et-1-MePy)2[SbBr6](Br3) monoclinic P21/n a 8.4645 b 13.0802 c 13.1574 β 105.702° [80]
bis(2,6-dimethylpyridin-1-ium) hexabromo-antimony pentabromide (2,6-MePy)2[SbBr6](Br5) monoclinic P21/c a 7.4584 b 18.0860 c 21.626 β 93.607° Z=4 2911.4 [79] (3)
bis(1,3,5-trimethylpyridin-1-ium) hexabromo-antimony tribromide (1,3,5-MePy)2[SbBr6](Br3) triclinic P1 a 8.1964 b 8.2015 c 12.5202 α 92.883° β 103.923° γ 115.467° Z=4 1085.3 100K [79] (4)
2,4,6-trimethylpyridinium (2,4,6-MePy)3[Sb2Br9] monoclinic P21/n a=10.36 b=42.36 c=9.09 β=100.2° Z=4 3926 2.25 yellow-tan [78]
2,4,6-trimethylpyridinium (2,4,6-MePy)[SbBr]•0.5Br2 monoclinic P21/n a 10.4938 b 13.6198 c 12.8807 β 90.339° Z=4 1840.9 100k [79] (5)
bis(3,5-dimethylpyridin-1-ium) hexabromo-antimony tribromide (3,5--MePy)2[SbBr6](Br3) orthorhombic Pnnm a 17.1097 b 10.4401 c 7.3438 Z=2 1311.8 [79] (2)
bis(1-ethyl-3-methylpyridinium) hexabromoantimonate tribromide (1-Et-3-MePy)2[SbBr6](Br3) triclinic P1 a 7.2472 b 9.4088 c 11.5541 α 69.263° β 81.162° γ 71.303° [80]
1-ethyl-4-methylpyridin-1-ium (1-Et-4-MePy)2[SbBr6](Br3) monoclinic P21/n a=11.4927 b=7.3613 c=16.9266 β=100.782° Sb(V) [97]
1-ethyl-2-methylpyridin-1-ium (1-Et-2-MePy)2[SbBr6](Br3) monoclinic P21/n a=8.3421 b=13.196 c=13.183 β=105.40° Sb(V) [97]
1-ethyl-2,6-dimethylpyridin-1-ium hexabromoantimonate (1-Et-2,6-MePy)[SbBr6] monoclinic P21/c a 9.9470 b 11.5017 c 16.4632 β 107.201° [80]
(PyC3)3[Sb2Br9]2 [98]
(PyC4)[Sb2Br8] [98]
(PyC5)2[α-Sb4Br16] [98]
(PyC6)2[Sb2Br10] [98]
(4-MePyC2)2[Sb2Br10] [98]
(4‑MePyC3)2[α-Sb4Br16] [98]
(4-MePyC5)2[α-Sb4Br16] [98]
1-benzylpyridin-1-ium hexabromoantimonate C6H5CH2PySbBr6 orthorhombic Pnma a=12.6594 b=17.3414 c=8.6389 Z=4 1896.5 [79] (6)
bis(1-benzyl-2-methylpyridinium) hexabromoantimonate tribromide (CH3-C6H5CH2Py)2SbBr6(Br3) triclinic P1 a 8.9834 b 10.2599 c 10.3601 α 94.223° β 102.737° γ 111.846° [80] (7)
bis(1-(4-bromobenzyl)pyridinium) hexabromoantimonate tribromide (BrC6H4CH2Py)2SbBr6(Br3) monoclinic P21/c a 8.6483 b 15.1885 c 13.3520 β 98.887° [80]
2,2'-bipyridinium pentabromoantimonate (III) (2,2'-C10H8N2H2)SbBr5 monoclinic P21/c a = 14.575 b = 14.726 c = 16.775 β = 110.34° Z = 8 [99]
4,4'-bipyridinium pentabromoantimonate (III) (4,4'-C10H8N2H2)SbBr5 triclinic P1 a = 11.28.7 b = 10.121 c = 8.548 α = 98.94° β = 101.06° γ = 113.57° Z = 2 [99]
imidazolium (C3N2H5)3SbBr6.H2O monoclinic P21/c a=8.9137 b=19.2032 c=12.7984 β=90.650° [100]
imidazolium (C3N2H5)5Sb2Br11 monoclinic P21/n a 9.1399 b 15.150 c 13.969 β 96.19° ferroelectric Curie Point 145K; 4 phases [100][101]
thiazolium (C3H4NS)6Sb4Br18·2H2O triclinic P1 a 11.060 b 11.465 c 12.957 α 116.21° β 100.71° γ 98.87° [102]
quinolinium monoclinic Cc a=15.28 b=14.04 c=7.44 β =118.3 Z=4 1405 2.70 light yellow [78]
quinolinium (C9H7NH)2SbBr9 monoclinic P21/n as=7.518 b=11.316 c=16.351 β =97.41 Z=2 Sb(V) [103]
3-Bromoquinolinium (3-BrQuinH)4[Sb2Br10] monoclinic C2/c a 15.3947 b 13.7967 c 22.8880 β 92.039° [104] 2
5-Bromoquinolinium (5-BrQuinH)2[SbBr5] monoclinic C2/c a 23.8681 b 12.2567 c 8.6474 β 106.128° [104] 3
3-Bromo-1-methylquinolinium (1-Me-3-BrQuin)3[Sb3Br12] triclinic P1 a 9.8582 b 11.7183 c 21.6576, α 98.981° β 96.402° γ 92.371° [104] 5
isoquinolinium isoquinHSbBr4 monoclinic P21/a a=13.11 b=14.14 c=7.57 β=91.4 Z=4 1403 2.71 light tan [78]
N-methyl quinolinium (N-MeQuin)2{[SbBr6](Br3)} triclinic P1 a=8.0902 b=8.5656 c=11.6475 𝛼 = 68.901° β = 79.204° 𝛾 = 77.120° Z=1 728.98 [105]
N-methyl isoquinolinium (N-MeIsoquin)2{[SbBr6](Br3)} monoclinic P21/c a=12.9656 b=9.3423 c=12.5920 β = 107.233° Z=2 1456.8 [105]
N-ethyl quinolinium (N-EtQuin)[SbBr6] orthorhombic Pnma a=14.5122 b=11.4005 c=11.2135° Z=4 1855.2 [105]
tris(6-methylquinolinium) hexabromoantimonate(III) (6-MeQuin)3[SbBr6] [106]
2-methyl-1,3-benzoxazole SbBr5(boxH)2 triclinic P1 a=8.560 b=11.008 c=12.751 α=102.836° β=106.173° γ=93.398° [107]
quinuclidinium (C9H7NH)2SbVBr9 monoclinic P21/n a=7.518 b=11.316 c=16.351 β=97.41° Z=2 2.67 red [108]
quinuclidinium (C7H13NH)4SbIIISbVBr12.2Br2 cubic Fm3m a=13.873 2670 2.45 black [109]
3-ammoniumpropyl imidazolium pentabromoantimonate (III) [C6H13N3]2+[SbBr5]2− orthorhombic P212121 8.7120 b = 12.6608 c = 14.3498 Z = 4 [110]
trihydroxonium enneabromidodiantimonate(III) (H3O)3Sb2Br9 monoclinic P21/n a = 13.4679 b = 7.6319 c = 19.1397 β = 90.240° Z=4 1967.3 3.443 yellow [111]
hexabromoantimonic(V) acid trihydrate HSbBr6 · 3H2O monoclinic P21/c a = 7.110 b = 13.532 c = 12.846 β = 94.87 Z=4 melt 330K [112]
tetramethylphosphonium [(CH3)4P]3[Sb2Br9] hexagonal P31/c a 9.7931 c 22.697 deep yellow [113]
trimethylphosphonium [(CH3)3PH][SbBr4] monoclinic P21/c a=10.9103 b=19.8342 c=11.3617 β=100.744 Z=4 2415.54 2.851 colourless [114]
Methyltriphenylphosphonium (MTP)6SbBr6Sb2Br9⋅H2O trigonal R3 a=19.7793 c=27.2770 Z=3 9241 1.749 [115]
Methyltriphenylphosphonium (MTP)2SbBr5 monoclinic P21/c a=12.7399 b=12.3833 c=26.0206 β=96.373 Z=4 4079.7 1.752 [115]
tetraphenylphosphonium P(C6H5)4SbBr6 monoclinic C2/c a = 16.887 b = 7.357 c = 23.367 β = 93.98° Z=4 2896.1 yellow [116]
triphenyl(9-phenyl-9H-carbazol-3-yl) phosphonium antimony bromide TPPcarzSbBr4 triclinic P1 a=9.77183 b=11.42472 16.15939 α=88.2199° β=80.7810° γ=71.8474°, Z = 2 1691.77 1.857 red LED [22]
Tetraphenylphosphonium Ikosioctabromooctaantimonate(III) (PPh4)4Sb8Br28 triclinic P1 a=12.491 b=13.078 c=21.523 α=102.93° β=100.83° γ= 100.42°, Z = 2 3273 2.318 [117]
Tris-Chlorobromophosphazeno-carbenium [C(NP(Br0,78Cl0,22)3)3]SbBr6 orthorhombic Pbca a = 27.92 b = 11.23 c = 17.54 Z = 8 [118]
Rb3Sb2Br9 monoclinic P21/n [119][120]
Rb4Sb2Br12 tetragonal I41/amd a = 10.70 and c = 21.69 Z=8 4.17 black [26][121][19]
Rb7Sb3Br16 orthorhombic Cmcm a = 23.4716 b = 13.57.89 c = 35.3947 yellow [120][122]
[RuNOPy4Br]4[Sb2Br8][Sb3Br12]2 monoclinic P21/c a=12.021 b=22.454 c=26.372 β=92.506° Z=8 7112 2.634 light orange [123]
1,4-bis(ammoniomethyl)cyclohexane (C8H20N2)2AgMBr8 triclinic P1 a 8.0820 b 8.161 c 11.814 α 90.185° β 95.390° γ 90.121° band gap 2.600 eV [124]
histammonium (HIS)2AgSbBr8 monoclinic C2/c a=11.5632 b=12.2529 c=18.694 β=94.264 Z=4 2641.3 2.754 semiconductor; pale yellow [21]
Cs3Sb2Br9 a=7.9165 c=9.7139 yellow; orange at 300°C; perovskite [125]
Cs4Sb2Br12 tetragonal I41/amd a=10.842 c=21.913 Z=2 2576 black @300K [26][126]
Cs2AgSbBr6 cubic Fm3m a = 11.1583 Z=4 1389.2 4.661 black; bandgap 1.64 eV [118]
Benzeneethanammonium (C8NH12)4Bi0.57Sb0.43Br7⋅H2O triclinic P1 a=13.0207 b=13.1304 c=13.3192 α=93.818° β=102.408° γ=108.610° Z=2 2085.1 1.971 light green [67]

References

[edit]
  1. ^ Holmes, Robert R. (October 1961). "Pressure measurements in the arsenic trichloride-chlorine system and the arsenic and antimony tribromide-bromine systems". Journal of Inorganic and Nuclear Chemistry. 19 (3–4): 363–366. doi:10.1016/0022-1902(61)80126-7.
  2. ^ Ballard, George Jack (July 1977). Spectroscopic Studies of Antimony III and V Halide Complexes (Thesis).
  3. ^ a b Bukvetskii, B. V.; Sedakova, T. V.; Mirochnik, A. G. (April 2009). "Crystal structure and luminescence of antimony(III) bromide with aniline". Journal of Structural Chemistry. 50 (2): 322–327. Bibcode:2009JStCh..50..322B. doi:10.1007/s10947-009-0044-9. ISSN 0022-4766. S2CID 95792428.
  4. ^ Okuda, Tsutomu; Tanaka, Nobuhiko; Ichiba, Sumio; Yamada, Koji (1986-02-01). "Nuclear Quadrupole Resonance in Chloro- and Bromoantimonate(III) Complexes". Zeitschrift für Naturforschung A. 41 (1–2): 319–325. Bibcode:1986ZNatA..41..319O. doi:10.1515/zna-1986-1-259. ISSN 1865-7109. S2CID 3515103.
  5. ^ Porter, S. K.; Jacobson, R. A. (1970). "Crystal structure of pyridinium nonabromodiantimonate(III) dibromide". Journal of the Chemical Society A: Inorganic, Physical, Theoretical: 1359. doi:10.1039/J19700001359.
  6. ^ Kolditz, Lothar; Schiller, Wolfgang (May 1969). "Über Hexabromoantimonat". Zeitschrift für anorganische und allgemeine Chemie. 366 (3–4): 163–168. doi:10.1002/zaac.19693660307.
  7. ^ a b c Adams, C.J.; Downs, A.J. (June 1972). "Features of the coordination chemistry of B-metals—II Bromoantimonates(V)". Journal of Inorganic and Nuclear Chemistry. 34 (6): 1829–1840. doi:10.1016/0022-1902(72)80530-X.
  8. ^ Schmidtke, Hans-Herbert; Krause, Barbara; Schönherr, Thomas (June 1990). "Optical Spectra of Hexahalogeno-Antimony (III) Complex Compounds". Berichte der Bunsengesellschaft für physikalische Chemie. 94 (6): 700–703. doi:10.1002/bbpc.19900940614.
  9. ^ Jha, N.K.; Kumari, Amrita; Prasad, R.S. (January 1981). "Mixed hexahaloantimonates(III)". Journal of Inorganic and Nuclear Chemistry. 43 (11): 3016–3019. doi:10.1016/0022-1902(81)80670-7.
  10. ^ Müller, Ulrich; Mohammed, Abdulalah T. (February 1986). "Pentabromothio-diarsenat und -diantimonat: Darstellung, Schwingungsspektren und Kristallstrukturen von PPh4[As2SBr5] und PPh4[Sb2SBr5]". Zeitschrift für anorganische und allgemeine Chemie. 533 (2): 65–72. doi:10.1002/zaac.19865330209.
  11. ^ Bertazzi, N.; Airoldi, Marta; Pellerito, L. (September 1975). "Complexes of organometallic compounds : XLIII. Synthesis and infrared spectra of fluoro-, chloro- and bromo-phenylantimonates(V)". Journal of Organometallic Chemistry. 97 (3): 399–403. doi:10.1016/S0022-328X(00)89306-7.
  12. ^ Bentley, F. F.; Finch, Arthur; Gates, P. N.; Ryan, F. J. (February 1972). "Existence of chlorobromoantimonates". Inorganic Chemistry. 11 (2): 413–414. doi:10.1021/ic50108a042.
  13. ^ Casteel, William J.; Kolb, Peter; LeBlond, Nicolas; Mercier, Hélène P. A.; Schrobilgen, Gary J. (1 January 1996). "Tetrachloro- and Tetrabromostibonium(V) Cations: Raman and 19 F, 121 Sb, and 123 Sb NMR Spectroscopic Characterization and X-ray Crystal Structures of SbCl 4 + Sb(OTeF 5 ) 6 - and SbBr 4 + Sb(OTeF 5 ) 6 -". Inorganic Chemistry. 35 (4): 929–942. doi:10.1021/ic950818z. PMID 11666267.
  14. ^ Jha, N.K.; Rizvi, S.S.A. (January 1976). "Preparative investigations of bromoantimonates(III)". Journal of Inorganic and Nuclear Chemistry. 38 (3): 401–405. doi:10.1016/0022-1902(76)80271-0.
  15. ^ a b c Bujak, Maciej; Zarychta, Bartosz; Kobel, Aleksandra; Zaleski, Jacek (2004-03-01). "Preparation, Crystal Structure at 298 and 90 K and Phase Transition in (C 2 H 5 NH 3 ) 2 [SbBr 5 ] Studied by the Single Crystal X-Ray Diffraction Method". Zeitschrift für Naturforschung B. 59 (3): 298–304. doi:10.1515/znb-2004-0311. ISSN 1865-7117. S2CID 100724080.
  16. ^ Oldenburg, Karin; Vogler, Arnd (1 November 1993). "Electronic Spectra and Photochemistry of Tin(II), Lead(II), Antimony(III), and Bismuth(III) Bromide Complexes in Solution". Zeitschrift für Naturforschung B. 48 (11): 1519–1523. doi:10.1515/znb-1993-1109. S2CID 35186839.
  17. ^ a b c d Tarasiewicz, J.; Jakubas, R.; Zaleski, J.; Baran, J. (March 2008). "Structural characterization, thermal, dielectric and spectroscopic properties of di(n-pentylammonium) pentabromoantimonate(III): [n-C5H11NH3]2[SbBr5]". Journal of Molecular Structure. 876 (1–3): 86–101. Bibcode:2008JMoSt.876...86T. doi:10.1016/j.molstruc.2007.06.005.
  18. ^ Jagodzinski, Paul W.; Laane, Jaan (February 1980). "Low frequency vibrational spectra of bromo-and iodoantimonates". Journal of Raman Spectroscopy. 9 (1): 22–27. Bibcode:1980JRSp....9...22J. doi:10.1002/jrs.1250090107.
  19. ^ a b Hubbard, Camden; Jacobson, Robert (1968-01-01). "The Crystal Structure of Rb4SbIIISbvBr12". Proceedings of the Iowa Academy of Science. 75 (1): 85–96. ISSN 0085-2236.
  20. ^ Thomas, Ankit Stephen (16 October 2022). "A Review on Antimony-based Perovskite Solar Cells". Equilibrium Journal of Chemical Engineering. 6 (2): 75–91. doi:10.20961/equilibrium.v6i2.64322. ISSN 2622-3430. S2CID 255740163.
  21. ^ a b Fan, Qingshun; Xu, Haojie; You, Shihai; Ma, Yu; Liu, Yi; Guo, Wuqian; Hu, Xinxin; Wang, Beibei; Gao, Changhao; Liu, Wei; Luo, Junhua; Sun, Zhihua (2023-04-22). "Centimeter-Sized Single Crystals of Dion-Jacobson Phase Lead-Free Double Perovskite for Efficient X-ray Detection". Small. 19 (34): e2301594. doi:10.1002/smll.202301594. ISSN 1613-6810. PMID 37086129. S2CID 258275973.
  22. ^ a b Liu, He; Shonde, Tunde Blessed; Gonzalez, Fabiola; Olasupo, Oluwadara Joshua; Lee, Sujin; Luong, Derek; Lin, Xinsong; Vellore Winfred, J.S. Raaj; Lochner, Eric; Fatima, Iqra; Hanson, Kenneth; Ma, Biwu (March 2023). "Efficient Red Light Emitting Diodes Based on a Zero-Dimensional Organic Antimony Halide Hybrid". Advanced Materials. 35 (9): 2209417. Bibcode:2023AdM....3509417L. doi:10.1002/adma.202209417. ISSN 0935-9648. PMID 36524448. S2CID 254804816.
  23. ^ Lawton, Stephen L.; Jacobson, Robert A. (May 1966). "The Crystal Structure of Ammonium Hexabromoantimonate, (NH 4 ) 4 Sb III Sb V Br 12". Inorganic Chemistry. 5 (5): 743–749. doi:10.1021/ic50039a011. ISSN 0020-1669.
  24. ^ Zuo, Chuantian; Ding, Liming (2017-06-01). "Lead-free Perovskite Materials (NH 4 ) 3 Sb 2 I x Br 9− x". Angewandte Chemie. 129 (23): 6628–6632. Bibcode:2017AngCh.129.6628Z. doi:10.1002/ange.201702265.
  25. ^ a b c d e Pugh, W. (1954). "Hydrazine. Part VII. Some halogeno-antimonites and -bismuthites of hydrazine". Journal of the Chemical Society (Resumed): 1385–1388. doi:10.1039/jr9540001385. ISSN 0368-1769.
  26. ^ a b c Furukawa, Yoshihiro; Terao, Hiromitsu (2002-07-01). "81 Br NQR and 1 H NMR of Guanidinium Hexabromoantimonate(V) [C(NH 2 ) 3 ]SbBr 6 : Phase Transition and Molecular Motion". Zeitschrift für Naturforschung A. 57 (6–7): 399–402. Bibcode:2002ZNatA..57..399F. doi:10.1515/zna-2002-6-719. ISSN 1865-7109. S2CID 93394742.
  27. ^ Terao, Hiromitsu; Furukawa, Yoshihiro; Miki, Satomi; Tajima, Fukue; Hashimoto, Masao (2005-12-24). "NQR, NMR and Crystal Structure Studies of [C(NH2)3]3Sb2Br9". Hyperfine Interactions. 159 (1–4): 211–216. doi:10.1007/s10751-005-9099-y. ISSN 0304-3843. S2CID 95437922.
  28. ^ Szklarz, P; Zaleski, J; Jakubas, R; Bator, G; Medycki, W; Falińska, K (2005-04-20). "The structure, phase transition and molecular dynamics of [C(NH 2 ) 3 ] 3 [Sb 2 Br 9 ]". Journal of Physics: Condensed Matter. 17 (15): 2509–2528. Bibcode:2005JPCM...17.2509S. doi:10.1088/0953-8984/17/15/021. ISSN 0953-8984. S2CID 96818420.
  29. ^ Bujak, Maciej; Zaleski, Jacek (2007-01-15). "Tris( N , N , N ′, N ′-tetramethylguanidinium) nonabromodiantimonate(III)". Acta Crystallographica Section E: Structure Reports Online. 63 (1): m102–m104. Bibcode:2007AcCrE..63M.102B. doi:10.1107/S1600536806051920. ISSN 1600-5368.
  30. ^ a b c d e Okuda, Tsutomu; Kinoshita, Yoshihiro; Terao, Hiromitsu; Yamada, Koji (1994-02-01). "Structure and Bonding of Bromoantimonate (III) Complexes with Unusual Valency by Means of NQR and Powder X-Ray Diffraction". Zeitschrift für Naturforschung A. 49 (1–2): 185–192. doi:10.1515/zna-1994-1-228. ISSN 1865-7109. S2CID 3503225.
  31. ^ Varma, Vijay; Bhattacharjee, Ramendu; Vasan, H.N.; Rao, C.N.R. (November 1992). "Infrared and Raman spectroscopic investigations of methylammonium haloantimonates(III), [N(CH3)4−nHn]3 Sb2X9 (n = 0–3, X = Cl or Br), through their phase transitions". Spectrochimica Acta Part A: Molecular Spectroscopy. 48 (11–12): 1631–1646. Bibcode:1992AcSpA..48.1631V. doi:10.1016/0584-8539(92)80237-Q.
  32. ^ Ishihara, Hideta; Watanabe, Koichi; Iwata, Ayako; Yamada, Koji; Kinoshita, Yoshihiro; Okuda, Tsutomu; Krishnan, V. G.; Dou, Shi-qi; Weiss, Alarich (1992-02-01). "NQR and X-ray Studies of [N(CH 3 ) 4 ] 3 M 2 X 9 and (CH 3 NH 3 ) 3 M 2 X 9 (M = Sb,Bi; X = Cl,Br)". Zeitschrift für Naturforschung A. 47 (1–2): 65–74. doi:10.1515/zna-1992-1-213. ISSN 1865-7109. S2CID 51832125.
  33. ^ Jakubas, R.; Sobczyk, L.; Matuszewski, J. (August 1987). "Ferroelectricity and phase transitions in tris (dimethylammonium) nonabromodiantimonate (III)". Ferroelectrics. 74 (1): 339–345. Bibcode:1987Fer....74..339J. doi:10.1080/00150198708201316. ISSN 0015-0193.
  34. ^ a b c d e f Jha, N.K.; Rizvi, S.S.A. (July 1974). "Some studies on bromoantimonate(III) complexes". Journal of Inorganic and Nuclear Chemistry. 36 (7): 1479–1489. doi:10.1016/0022-1902(74)80610-X.
  35. ^ Hall, Michael; Nunn, Michael; Begley, Michael J.; Sowerby, D. Bryan (1986). "Nonahalogenodiantimon(III)ates; their preparation and the crystal structures of [Hpy]3[Sb2Cl9], [NMe4]3[Sb2Br9], and [NMe4]3[Sb2Br3Cl6]". Journal of the Chemical Society, Dalton Transactions (6): 1231–1238. doi:10.1039/dt9860001231. ISSN 0300-9246.
  36. ^ Petzold, Walter (1933-11-10). "Komplexe Bromoverbindungen des Antimons". Zeitschrift für anorganische und allgemeine Chemie (in German). 215 (1): 92–102. doi:10.1002/zaac.19332150111. ISSN 0863-1786.
  37. ^ Hubbard, Camden R.; Jacobson, Robert A. (September 1972). "Molecular bromine bridging of SbIII2Br93- anions and the crystal structure of tetraethylammonium nonabromodiantimonate(III)-dibromine". Inorganic Chemistry. 11 (9): 2247–2250. doi:10.1021/ic50115a053. ISSN 0020-1669.
  38. ^ Hubbard, Camden Richards (1971-09-01). "Crystal structure determinations of rubidium hexabromoantimonate (III, V) and tetramethylammonium nonabromodiantimonate (III) dibromine and a highly efficient white radiation neutron diffraction technique": IS–T–-476, 4709000. doi:10.2172/4709000. {{cite journal}}: Cite journal requires |journal= (help)
  39. ^ a b c Adonin, Sergey A.; Udalova, Liubov I.; Abramov, Pavel A.; Novikov, Alexander S.; Yushina, Irina V.; Korolkov, Ilya V.; Semitut, Evgeniy Y.; Derzhavskaya, Tatiyana A.; Stevenson, Keith J.; Troshin, Pavel A.; Sokolov, Maxim N.; Fedin, Vladimir P. (2018-10-01). "A Novel Family of Polyiodo-Bromoantimonate(III) Complexes: Cation-Driven Self-Assembly of Photoconductive Metal-Polyhalide Frameworks". Chemistry - A European Journal. 24 (55): 14707–14711. doi:10.1002/chem.201802100. PMID 30020549. S2CID 51676863.
  40. ^ Rosenheim, Arthur; Stellmann, Wilhelm (October 1901). "Ueber die Pentahalogenide des Antimons und ihre Doppelverbindungen" (PDF). Berichte der Deutschen Chemischen Gesellschaft. 34 (3): 3377–3384. doi:10.1002/cber.19010340322. ISSN 0365-9496.
  41. ^ a b Okuda, Tsutomu; Hiura, Morio; Koshimizu, Etsuo; Ishihara, Hideta; Kushi, Yoshihiko; Negita, Hisao (1982-09-05). "The NQR and Structure of Hexabromoantimonate(III) and Bismuthate(III) Ions". Chemistry Letters. 11 (9): 1321–1324. doi:10.1246/cl.1982.1321. ISSN 0366-7022.
  42. ^ Miniewicz, A.; Jakubas, R.; Zaleski, J. (June 1991). "Measurements of pyroelectric properties in [(C 2 H 5 ) 4 N] 3 Sb 2 Br 9". Ferroelectrics. 118 (1): 23–28. Bibcode:1991Fer...118...23M. doi:10.1080/00150199108014740. ISSN 0015-0193.
  43. ^ Zaleski, J.; Jakubas, R.; Galewski, Z.; Sobczyk, L. (1989-11-01). "Structural Phase Transitions in [(C 2 H 5 ) 4 N] 3 Sb 2 Br 9 and [(C 2 H 5 ) 4 N] 3 Bi 2 Br 9". Zeitschrift für Naturforschung A. 44 (11): 1102–1106. Bibcode:1989ZNatA..44.1102Z. doi:10.1515/zna-1989-1110. ISSN 1865-7109. S2CID 101200132.
  44. ^ a b Clark, Robin J. H.; Duarte, Maria Lenor (1977). "Raman, resonance-Raman, and electronic spectra of tetraethylammonium hexabromoantimonate(V) and of tetra-n-butylammonium hexa-bromoantimonate(V)". Journal of the Chemical Society, Dalton Transactions (8): 790–793. doi:10.1039/dt9770000790. ISSN 0300-9246.
  45. ^ Jacobson, Robert A.; Hackert, Marvin L.; Keiderling, Timothy A. (May 1971). "Crystal structure of tetraethylammonium hexabromoantimonate(V), (C2H5)4NSbBr6". Inorganic Chemistry. 10 (5): 1075–1078. doi:10.1021/ic50099a044. ISSN 0020-1669.
  46. ^ N., Pislewski; J., Tritt-Goc; R., Jakubas. "Study on phase transitions and dynamics of n-propyl amine groups in (n-C3H7NH3)2SbBr5" (in Polish). {{cite journal}}: Cite journal requires |journal= (help)
  47. ^ Jakubas, R.; Bator, G.; Foulon, M.; Lefebvre, J.; Matuszewski, J. (1993-03-01). "Structural Phase Transitions in (n-C 3 H 7 NH 3 ) 2 SbBr 5". Zeitschrift für Naturforschung A. 48 (3): 529–534. Bibcode:1993ZNatA..48..529J. doi:10.1515/zna-1993-0314. ISSN 1865-7109. S2CID 102140570.
  48. ^ Weslati, Najoua; Elgahami, Hanen; Hamdi, Mohamed; Oueslati, Abderrazek; Naïli, Houcine (June 2022). "Crystal structure, phase transition and electrical conductivity studies of [(C3H7)4N][SbBr4] compound". Journal of the Iranian Chemical Society. 19 (6): 2481–2493. doi:10.1007/s13738-021-02472-w. ISSN 1735-207X. S2CID 246235582.
  49. ^ Tritt-Goc, By J.; Pislewski, N.; Goc, R.; Jakubas, H. PISLEWSKA and R. (November 1997). "Molecular motion in solid \[(CH3)2 CHNH3]2 BiBr5 and \[(CH3)2 CHNH3]2SbBr5 as studied by proton nuclear magnetic resonance". Molecular Physics. 92 (4): 687–692. Bibcode:1997MolPh..92..687T. doi:10.1080/002689797169961. ISSN 0026-8976.
  50. ^ Jakubas, R; Bator, G; Ciapala, P; Zaleski, J; Baran, J; Lefebvre, J (1995-07-03). "Calorimetric, dielectric, infrared spectra and thermal expansion studies of structural phase transitions in ((CH 3 ) 2 CHNH 3 ) 2 MX 5 (M=Sb, Bi; X=Cl, Br) crystals". Journal of Physics: Condensed Matter. 7 (27): 5335–5350. Bibcode:1995JPCM....7.5335J. doi:10.1088/0953-8984/7/27/018. ISSN 0953-8984. S2CID 250915716.
  51. ^ a b Petrov, M. D.; Sokolov, M. N.; Fedin, V. P.; Adonin, S. A. (November 2020). "CRYSTAL STRUCTURES OF POLYNUCLEAR ANTIMONY BROMIDECOMPLEXES (Et(n-Pr)3N)3[Sb3Br12] AND (2,2′-bipyH)4[Sb4Br20]". Journal of Structural Chemistry. 61 (11): 1794–1799. doi:10.1134/S0022476620110128. ISSN 0022-4766. S2CID 229372408.
  52. ^ Jakubas, R.; Jóźków, J.; Bator, G.; Zaleski, J.; Baran, J.; François, P. (December 1997). "Phase transitions in i-butylammonium halogenoantimonate(III) and bismuthate(III) crystals". Journal of Molecular Structure. 436–437: 315–325. Bibcode:1997JMoSt.436..315J. doi:10.1016/S0022-2860(97)00213-5.
  53. ^ Chaabouni, S.; Kamoun, S.; Jaud, J. (March 1998). "Calorimetric Studies and Crystal Structure of [C2H10N2]5(Sb2Br11)2·4H2O". Materials Research Bulletin. 33 (3): 377–388. doi:10.1016/S0025-5408(97)00251-1.
  54. ^ Kharrat, Houda; Kamoun, Slaheddine; Michaud, François (2013-12-15). "catena -Poly[ N , N , N ′, N ′-tetramethylethylendiammonium [[tetrabromidoantimonate(III)]-μ-bromido] hemihydrate]". Acta Crystallographica Section E: Structure Reports Online. 69 (12): m637–m638. doi:10.1107/S1600536813028894. ISSN 1600-5368. PMC 3884981. PMID 24454156.
  55. ^ Bujak, Maciej (January 2015). "Primary- and secondary-octahedral distortion factors in bis(1,4-H2-1,2,4-triazolium) pentabromidoantimonate(III)–1,4-H2-1,2,4-triazolium bromide". Polyhedron. 85: 499–505. doi:10.1016/j.poly.2014.09.009.
  56. ^ Chański, Michał; Białońska, Agata; Jakubas, Ryszard; Rok, Magdalena; Zaręba, Jan K.; Janicki, Rafał; Durlak, Piotr; Piecha-Bisiorek, A. (2023-05-18). "Progressive Structural Complexity in Ferroelectric 1,2,4-Triazolium Hexabromoantimonate(III): Interplay of "Order–Disorder" and "Displacive" Contributions to the Structural Phase Transitions". The Journal of Physical Chemistry Letters. 14 (19): 4524–4531. doi:10.1021/acs.jpclett.3c00924. ISSN 1948-7185. PMC 10201570. PMID 37159252.
  57. ^ a b c Płowaś, I.; Białońska, A.; Jakubas, R.; Bator, G.; Zarychta, B.; Baran, J. (September 2010). "Structural characterization, thermal, dielectric and vibrational properties of tris(allylammonium) hexabromoantimonate(III), (C3H5NH3)3SbBr6". Chemical Physics. 375 (1): 16–25. Bibcode:2010CP....375...16P. doi:10.1016/j.chemphys.2010.07.012.
  58. ^ a b Tarasiewicz, J.; Jakubas, R.; Baran, J.; Pietraszko, A. (July 2004). "On the structural phase transitions in [n-C4H9NH3]2[SbBr5]: thermal, dielectric and infrared studies". Journal of Molecular Structure. 697 (1–3): 161–171. Bibcode:2004JMoSt.697..161T. doi:10.1016/j.molstruc.2004.03.050.
  59. ^ Song, Ning; Chen, Shaopeng; Fan, Xiaowei; Tan, Yuhui; Tang, Yunzhi; Wang, Lijuan; Liao, Juan; Sun, Zhen (2022). "Tunable hybrid perovskites with a narrow bandgap and multistage phase transition properties: 2,2-difluoroethylamine·antimony hexabromide". CrystEngComm. 24 (21): 3872–3878. doi:10.1039/D2CE00438K. ISSN 1466-8033.
  60. ^ a b Mao, Chen-Yu; Liao, Wei-Qiang; Wang, Zhong-Xia; Zafar, Zainab; Li, Peng-Fei; Lv, Xing-Hui; Fu, Da-Wei (2016-08-01). "Temperature-Triggered Dielectric-Optical Duple Switch Based on an Organic–Inorganic Hybrid Phase Transition Crystal: [C 5 N 2 H 16 ] 2 SbBr 5". Inorganic Chemistry. 55 (15): 7661–7666. doi:10.1021/acs.inorgchem.6b01107. ISSN 0020-1669. PMID 27414504.
  61. ^ Essalhi, Rim; Abdelbaky, Mohammed S.M.; Elleuch, Slim; Zouari, Fatma; García-Granda, Santiago (December 2020). "Crystal structure, Hirschfield surface analysis, thermal and DFT investigation accomplished with photoluminescence study of bis(N, N-diethylethylendiammonium)decabromodiantimoinate(III)". Journal of Molecular Structure. 1221: 128828. Bibcode:2020JMoSt122128828E. doi:10.1016/j.molstruc.2020.128828. hdl:10261/234567. S2CID 224978285.
  62. ^ a b Zhang, Han-Yue; Mei, Guang-Quan; Liao, Wei-Qiang (2016-10-05). "Symmetry Breaking Phase Transition, Second-Order Nonlinear Optical and Dielectric Properties of a One-Dimensional Organic–Inorganic Hybrid Zigzag Chain Compound [NH 3 (CH 2 ) 5 NH 3 ]SbBr 5". Crystal Growth & Design. 16 (10): 6105–6110. doi:10.1021/acs.cgd.6b01179. ISSN 1528-7483.
  63. ^ Jaschinski, Bernd; Blachnik, Roger; Reuter, Hans (April 1999). "Ethyldimethylphenylammonium-halogenoantimonate(III)". Zeitschrift für anorganische und allgemeine Chemie (in German). 625 (4): 667–672. doi:10.1002/(SICI)1521-3749(199904)625:4<667::AID-ZAAC667>3.0.CO;2-B. ISSN 0044-2313.
  64. ^ Kharrat, Houda; Kamoun, Slaheddine; Michaud, François (2013-07-15). "Tris( N , N -dimethylanilinium) tri-μ-bromido-bis[tribromidoantimonate(III)]". Acta Crystallographica Section E: Structure Reports Online. 69 (7): m353. Bibcode:2013AcCrE..69M.353K. doi:10.1107/S1600536813014335. ISSN 1600-5368. PMC 3772401. PMID 24046544.
  65. ^ Mousdis, George A.; Ganotopoulos, Nikolaos-Minas; Barkaoui, Hamdi; Abid, Younes; Psycharis, Vassilis; Savvidou, Aikaterini; Raptopoulou, Catherine P. (2017-08-02). "One-Dimensional Organic–Inorganic Hybrid Materials Based on Antimony". European Journal of Inorganic Chemistry. 2017 (28): 3401–3408. doi:10.1002/ejic.201700277. ISSN 1434-1948.
  66. ^ a b c Li, Maofan; Teng, Bing; Han, Shiguo; Yang, Tao; Li, Yaobin; Liu, Yi; Zhang, Xinyuan; Liu, Xitao; Luo, Junhua; Sun, Zhihua (2019). "Near-room-temperature tunable dielectric response induced by dual phase transitions in a lead-free hybrid: (C 3 H 8 N) 2 SbBr 5". CrystEngComm. 21 (24): 3740–3744. doi:10.1039/C9CE00458K. ISSN 1466-8033. S2CID 182282425.
  67. ^ a b Zhang, Ruiling; Mao, Xin; Yang, Yang; Yang, Songqiu; Zhao, Wenyuan; Wumaier, Tuerdi; Wei, Donghui; Deng, Weiqiao; Han, Keli (2019-02-25). "Air-Stable, Lead-Free Zero-Dimensional Mixed Bismuth-Antimony Perovskite Single Crystals with Ultra-broadband Emission". Angewandte Chemie International Edition. 58 (9): 2725–2729. doi:10.1002/anie.201812865. ISSN 1433-7851. PMID 30663267. S2CID 58644281.
  68. ^ Chen, Da; Dai, Fulong; Hao, Shiqiang; Zhou, Guojun; Liu, Quanlin; Wolverton, Christopher; Zhao, Jing; Xia, Zhiguo (2020). "Crystal structure and luminescence properties of lead-free metal halides (C 6 H 5 CH 2 NH 3 ) 3 MBr 6 (M = Bi and Sb)". Journal of Materials Chemistry C. 8 (22): 7322–7329. doi:10.1039/D0TC00562B. ISSN 2050-7526. OSTI 1777408. S2CID 216208053.
  69. ^ Wang, Zhiyu; Zhang, Zixuan; Sung, Herman H. Y.; Williams, Ian D.; Lu, Haipeng (2022-08-19). "Structural Asymmetry and Chiroptical Activity of Chiral Antimony-Halide Hybrids". European Journal of Inorganic Chemistry. 2022 (23). doi:10.1002/ejic.202200275. ISSN 1434-1948.
  70. ^ a b c d e f g h i Hackert, M.; Lawton, S.; Jacobson, R. (1968-01-01). "Properties of lntervalence Antimony Bromides". Proceedings of the Iowa Academy of Science. 75 (1): 97–108. ISSN 0085-2236.
  71. ^ a b Sun, Zhihua; Zeb, Aurang; Liu, Sijie; Ji, Chengmin; Khan, Tariq; Li, Lina; Hong, Maochun; Luo, Junhua (2016-09-19). "Exploring a Lead-free Semiconducting Hybrid Ferroelectric with a Zero-Dimensional Perovskite-like Structure". Angewandte Chemie. 128 (39): 12033–12037. Bibcode:2016AngCh.12812033S. doi:10.1002/ange.201606079. ISSN 0044-8249.
  72. ^ Tang, Hao; Zheng, Pengfei; Xiao, Zhifeng; Yuan, Kejia; Zhang, Hanwen; Zhao, Xiaochen; Zhou, Wei; Wang, Shouyu; Liu, Weifang (2024-02-27). "Crystal Structure and Optical Properties Characterization in Quasi-0D Lead-Free Bromide Crystals (C 6 H 14 N) 3 Bi 2 Br 9 ·H 2 O and (C 6 H 14 N) 3 Sb 3 Br 12". Inorganic Chemistry. 63 (10): 4747–4757. doi:10.1021/acs.inorgchem.4c00052. ISSN 0020-1669.
  73. ^ Bujak, Maciej; Siodłak, Dawid (2020-03-17). "Isostructural Inorganic–Organic Piperazine-1,4-diium Chlorido- and Bromidoantimonate(III) Monohydrates: Octahedral Distortions and Hydrogen Bonds". Molecules. 25 (6): 1361. doi:10.3390/molecules25061361. ISSN 1420-3049. PMC 7144372. PMID 32192110.
  74. ^ Owczarek, Magdalena; Jakubas, Ryszard; Pietraszko, Adam; Medycki, Wojciech; Baran, Jan (2013). "Investigation of structure–properties relationship in a novel family of halogenoantimonates(iii) and halogenobismuthates(iii) with morpholinium cation: [NH2(C2H4)2O]MX4. Crystal structure, phase transitions and dynamics of molecules". Dalton Transactions. 42 (42): 15069–15079. doi:10.1039/c3dt51726h. ISSN 1477-9226. PMID 23999763.
  75. ^ Owczarek, Magdalena; Szklarz, Przemysław; Jakubas, Ryszard; Miniewicz, Andrzej (2012). "[NH2(C2H4)2O]MX5: a new family of morpholinium nonlinear optical materials among halogenoantimonate(iii) and halogenobismuthate(iii) compounds. Structural characterization, dielectric and piezoelectric properties". Dalton Transactions. 41 (24): 7285–7294. doi:10.1039/c2dt30291h. ISSN 1477-9226. PMID 22572794.
  76. ^ a b Yamada, K.; Ohtani, T.; Shirakawa, S.; Ohki, H.; Okuda, T.; Kamiyama, T.; Oikawa, K. (1996-06-01). "Phase Transition of C 5 H 5 NHSbBr 4 Having a Hypervalent Bond: A 2 H NMR and X-Ray Diffraction Study [Phase Transition of C 5 H 5 NHSbBr 4 ]". Zeitschrift für Naturforschung A. 51 (5–6): 739–744. Bibcode:1996ZNatA..51..739Y. doi:10.1515/zna-1996-5-664. ISSN 1865-7109. S2CID 98228504.
  77. ^ Anyfantis, George C.; Ganotopoulos, Nikolaos-Minas; Savvidou, Aikaterini; Raptopoulou, Catherine P.; Psycharis, Vassilis; Mousdis, George A. (September 2018). "Synthesis and characterization of new organic–inorganic hybrid compounds based on Sb, with a perovskite like structure". Polyhedron. 151: 299–305. doi:10.1016/j.poly.2018.05.024. S2CID 102517360.
  78. ^ a b c d e f g h i j k l m n o p q r Stewart, James M.; McLaughlin, Kevin L.; Rossiter, Joseph J.; Hurst, John R.; Haas, Raymond G.; Rose, Valerie J.; Ciric, Barbara E.; Murphy, Joan A.; Lawton, Stephen L. (1974-11-01). "Preparation, characterization, and crystallographic data of some substituted-pyridinium antimony(III) bromide salts". Inorganic Chemistry. 13 (11): 2767–2769. doi:10.1021/ic50141a046. ISSN 0020-1669.
  79. ^ a b c d e f Adonin, Sergey A.; Bondarenko, Mikhail A.; Abramov, Pavel A.; Novikov, Alexander S.; Plyusnin, Pavel E.; Sokolov, Maxim N.; Fedin, Vladimir P. (2018-07-17). "Bromo- and Polybromoantimonates(V): Structural and Theoretical Studies of Hybrid Halogen-Rich Halometalate Frameworks". Chemistry – A European Journal. 24 (40): 10165–10170. doi:10.1002/chem.201801338. ISSN 0947-6539. PMID 29683216. S2CID 5041888.
  80. ^ a b c d e f g h i j k l Adonin, Sergey A.; Bondarenko, Mikhail A.; Novikov, Alexander S.; Abramov, Pavel A.; Plyusnin, Pavel E.; Sokolov, Maxim N.; Fedin, Vladimir P. (2019). "Halogen bonding-assisted assembly of bromoantimonate( v ) and polybromide-bromoantimonate-based frameworks". CrystEngComm. 21 (5): 850–856. doi:10.1039/C8CE01944D. ISSN 1466-8033. S2CID 104450943.
  81. ^ Kulicka, B.; Jakubas, R.; Ciunik, Z. (October 2006). "Structural characterization and properties of [4-CH3C5H4NH][SbBr4]. The mechanism of phase transitions in 4-methylpyridinium bromoantimonates(III)". Solid State Sciences. 8 (10): 1229–1236. Bibcode:2006SSSci...8.1229K. doi:10.1016/j.solidstatesciences.2006.05.013.
  82. ^ Ishihara, Hideta; Dou, Shi-qi; Weiss, Alarich (March 1994). "NQR and X-Ray Study of Bis(4-methylpyridinium) Pentabromoantimonate(III), (4-CH 3 C 5 H 4 NH) 2 SbBr 5". Bulletin of the Chemical Society of Japan. 67 (3): 637–640. doi:10.1246/bcsj.67.637. ISSN 0009-2673.
  83. ^ Lawton, Stephen L.; Hoh, David M.; Johnson, Robert C.; Knisely, Alexander S. (February 1973). "Crystal structure of 4-methylpyridinium nonabromoantimonate(V), (4-C6H7NH)2SbVBr9". Inorganic Chemistry. 12 (2): 277–283. doi:10.1021/ic50120a006. ISSN 0020-1669.
  84. ^ Lawton, Stephen L.; Jacobson, Robert A. (October 1968). "Crystal structure of di-.alpha.-picolinium nonabromoantimonate(V)". Inorganic Chemistry. 7 (10): 2124–2134. doi:10.1021/ic50068a036. ISSN 0020-1669.
  85. ^ a b Adonin, Sergey A.; Bondarenko, Mikhail A.; Samsonenko, Denis G.; Semitut, Evgeniy Yu; Sokolov, Maxim N.; Fedin, Vladimir P. (May 2018). "Mononuclear bromide complexes of Sb(V): crystal structures and thermal behaviour". Journal of Molecular Structure. 1160: 102–106. Bibcode:2018JMoSt1160..102A. doi:10.1016/j.molstruc.2018.01.092.
  86. ^ a b Adonin, S. A.; Bondarenko, M. A.; Abramov, P. A.; Korolkov, I. V.; Plyusnin, P. E.; Sokolov, M. N.; Fedin, V. P. (February 2019). "Mononuclear Sb(V) Bromide Complexes with 3-Halopyridinium Cations: Synthesis, Structures, and Thermal Stability". Russian Journal of Coordination Chemistry. 45 (2): 128–132. doi:10.1134/S1070328419020027. ISSN 1070-3284. S2CID 150157692.
  87. ^ Terao, Hiromitsu; Ninomiya, Seiko; Hashimoto, Masao; Eda, Kazuo (February 2010). "81Br NQR and crystal structure of 4-bromopyridinium pentabromoantimonate(III); 3c–4e bonding and NQR trans influence". Journal of Molecular Structure. 965 (1–3): 68–73. Bibcode:2010JMoSt.965...68T. doi:10.1016/j.molstruc.2009.11.040.
  88. ^ Bondarenko, M. A.; Adonin, S. A.; Novikov, A. S.; Sokolov, M. N.; Fedin, V. P. (May 2020). "Supramolecular Bromoantimonate(V) Polybromide (2,6-BrPyH)3[SbBr6]{(Br2)Br} · 2H2O: Specific Features of Halogen···Halogen Contacts in the Crystal Structure". Russian Journal of Coordination Chemistry. 46 (5): 302–307. doi:10.1134/S1070328420040016. ISSN 1070-3284. S2CID 218624447.
  89. ^ Egger, David A. (2018-08-16). "Intermediate Bands in Zero-Dimensional Antimony Halide Perovskites". The Journal of Physical Chemistry Letters. 9 (16): 4652–4656. arXiv:1805.09560. doi:10.1021/acs.jpclett.8b01730. ISSN 1948-7185. PMID 30052447. S2CID 51728397.
  90. ^ Kulicka, B; Jakubas, R; Bator, G; Ciunik, Z; Medycki, W (2004-11-24). "Structure and properties of [2-NH 2 C 5 H 4 NH][SbCl 4 ] and [2-NH 2 C 5 H 4 NH][SbBr 4 ]". Journal of Physics: Condensed Matter. 16 (46): 8155–8172. Bibcode:2004JPCM...16.8155K. doi:10.1088/0953-8984/16/46/004. ISSN 0953-8984. S2CID 250876595.
  91. ^ Hashimoto, Masao; Terao, Hiromitsu; Fuess, Hartmut; Svoboda, Ingrid; Ehrenberg, Helmut (April 2003). "Crystal Structure, Hydrogen Bonding, and 81 Br NQR of Low-Temperature Phase of 4-Aminopyridinium Tetrabromoantimonate(III)". Bulletin of the Chemical Society of Japan. 76 (4): 749–753. doi:10.1246/bcsj.76.749. ISSN 0009-2673.
  92. ^ a b c Bondarenko, Mikhail A.; Abramov, Pavel A.; Plyusnin, Pavel E.; Novikov, Alexander S.; Sokolov, Maxim N.; Adonin, Sergey A. (July 2021). "Bromoantimonates with bis(pyridinium)-type dications obtained via oxidation by dibromine: Diverse structural types and features of interactions pattern". Polyhedron. 202: 115217. doi:10.1016/j.poly.2021.115217. S2CID 234829102.
  93. ^ a b c d e Usoltsev, Andrey N.; Sukhikh, Taisiya S.; Novikov, Alexander S.; Shayapov, Vladimir R.; Pishchur, Denis P.; Korolkov, Ilya V.; Sakhapov, Ilyas F.; Fedin, Vladimir P.; Sokolov, Maxim N.; Adonin, Sergey A. (2021-02-15). "Unexpected Polymorphism in Bromoantimonate(III) Complexes and Its Effect on Optical Properties". Inorganic Chemistry. 60 (4): 2797–2804. doi:10.1021/acs.inorgchem.0c03699. ISSN 0020-1669. PMID 33496171. S2CID 231710405.
  94. ^ Bondarenko, Mikhail A.; Novikov, Alexander S.; Fedin, Vladimir P.; Sokolov, Maxim N.; Adonin, Sergey A. (2020-11-16). "The stabilization of decabromide {Br 10 } 2− anion in the structure of Sb(V) bromide complex". Journal of Coordination Chemistry. 73 (20–22): 3038–3043. doi:10.1080/00958972.2020.1837785. ISSN 0095-8972. S2CID 228993870.
  95. ^ a b c Usol’tsev, A. N.; Sokolov, M. N.; Fedin, V. P.; Adonin, S. A. (June 2021). "Bi- and Tetranuclear Antimony(III) Bromide Complexes with Alkanediyl-bis(3-methylpyridinium) Cations". Russian Journal of Inorganic Chemistry. 66 (6): 827–833. doi:10.1134/S003602362106019X. ISSN 0036-0236. S2CID 235663960.
  96. ^ a b Usol’tsev, A. N.; Petrov, M. D.; Korol’kov, I. V.; Sokolov, M. N.; Blatov, V. A.; Adonin, S. A. (September 2021). "Bromide Complexes of Sb(III) with the 4,4'-Dimethyl-1,1'-Butanediylbis(pyridinium) Cation: Unexpected Formation of Polymorphs with Complex Cations of Various Nuclearity". Russian Journal of Coordination Chemistry. 47 (9): 620–625. doi:10.1134/S107032842108008X. ISSN 1070-3284. S2CID 237474819.
  97. ^ a b c d e Adonin, Sergey A.; Bondarenko, Mikhail A.; Novikov, Alexander S.; Plyusnin, Pavel E.; Korolkov, Ilya V.; Sokolov, Maxim N.; Fedin, Vladimir P. (March 2020). "Five new Sb(V) bromide complexes and their polybromide derivatives with pyridinium-type cations: Structures, thermal stability and features of halogen⋯halogen contacts in solid state". Inorganica Chimica Acta. 502: 119278. doi:10.1016/j.ica.2019.119278. S2CID 209721773.
  98. ^ a b c d e f g Usoltsev, A. N.; Korol’kov, I. V.; Adonin, S. A. (June 2023). "Bromoantimonates(III) vs. Bromobismuthates(III): Differences in the Tendency for the Formation of Polynuclear Complexes". Russian Journal of Coordination Chemistry. 49 (6): 345–349. doi:10.1134/S1070328423700598. ISSN 1070-3284. S2CID 259254579.
  99. ^ a b Ishihara, Hideta; Dou, Shi-Qi; Weiss, Alarich (June 1991). "The Mutual Influence of Ligands in Sb(III) Complex Salts. An X-Ray Diffraction and NQR Study". Berichte der Bunsengesellschaft für physikalische Chemie. 95 (6): 659–670. doi:10.1002/bbpc.19910950602.
  100. ^ a b Piecha, A.; Gągor, A.; Pietraszko, A.; Jakubas, R. (December 2010). "Unprecedented solid-state chemical reaction—from . From centrosymmetric to non-centrosymmetric crystal structure". Journal of Solid State Chemistry. 183 (12): 3058–3066. doi:10.1016/j.jssc.2010.10.020.
  101. ^ Piecha, A.; Pietraszko, A.; Bator, G.; Jakubas, R. (May 2008). "Structural characterization and ferroelectric ordering in (C3N2H5)5Sb2Br11". Journal of Solid State Chemistry. 181 (5): 1155–1166. Bibcode:2008JSSCh.181.1155P. doi:10.1016/j.jssc.2008.02.029.
  102. ^ Piecha, A.; Jakubas, R.; Kinzhybalo, V.; Medycki, W. (April 2012). "Crystal structure, dielectric properties and molecular motions of molecules in thiazolium halometalates(III): (C3H4NS)6M4Br18·2H2O (M=Sb, Bi)". Journal of Molecular Structure. 1013: 55–60. Bibcode:2012JMoSt1013...55P. doi:10.1016/j.molstruc.2012.01.014.
  103. ^ McAfee, Elwin Ray (1970-11-01). "The crystal structure of quinolinium nonabromoantimonate (V), (C9H7NH)2SbVBr9 and the refinement of the molecular structure of beta-picoline-n-oxide fumaric acid adduct". doi:10.2172/4036792. OSTI 4036792. {{cite journal}}: Cite journal requires |journal= (help)
  104. ^ a b c Shentseva, Irina A.; Korobeynikov, Nikita A.; Usoltsev, Andrey N.; Gorokh, Igor D.; Novikov, Alexander S.; Korolkov, Ilya V.; Sokolov, Maxim N.; Adonin, Sergey A. (June 2023). "Haloantimonate(III) complexes with halogen-substituted quinolinium cations: structural features of non-covalent interactions in solid state". Polyhedron. 242: 116505. doi:10.1016/j.poly.2023.116505. S2CID 259796849.
  105. ^ a b c Adonin, Sergey A.; Bondarenko, Mikhail A.; Novikov, Alexander S.; Abramov, Pavel A.; Plyusnin, Pavel E.; Sokolov, Maxim N.; Fedin, Vladimir P. (2019-10-14). "Antimony(V) Bromide and Polybromide Complexes with N-alkylated Quinolinium or Isoquinolinium Cations: Substituent-dependent Assembly of Polymeric Frameworks: Antimony(V) Bromide and Polybromide Complexes with N-alkylated Quinolinium or Isoquinolinium Cations: Substituent-dependent Assembly of Polymeric Fram". Zeitschrift für anorganische und allgemeine Chemie. 645 (18–19): 1141–1145. doi:10.1002/zaac.201900165. S2CID 204138784.
  106. ^ Bukvetskiǐ B.V., Storozhuk T.V., Mirochnik A.G., Petrochenkova N.V., Karasev V.E. (2004). "CИНТЕЗ, КРИСТАЛЛИЧЕСКАЯ СТРУКТУРА И СПЕКТРАЛЬНОЛЮМИНЕСЦЕНТНЫЕ СВОЙСТВА КОМПЛЕКСНЫХ СОЕДИНЕНИЙ ГАЛОГЕНИДОВ СУРЬМЫ(III) С 6-МЕТИЛХИНОЛИНОМ" [SYNTHESIS, CRYSTAL STRUCTURE, AND LUMINESCENT PROPERTIES OF ANTIMONY(III) HALIDE COMPLEXES WITH 6-METHYLQUINOLINE]. Russian Journal of Inorganic Chemistry. 49 (1): 43–50.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  107. ^ Ly, Kathy; May, Kathleen L.; Lough, Alan J.; Zhu, Jianfeng; Quail, J. Wilson; Gossage, Robert A. (February 2023). "Synthesis and structural characterisation of trivalent halidoantimonates and bismuthates of 2-methyl-2-benzoxazole (box): Reactivity and solid-state structural diversity within the [MX(6 – n)] [boxH](3 – n) series (M = Sb or Bi; X = Cl, Br, I; n = 0 or 1)". Journal of Solid State Chemistry. 318: 123653. Bibcode:2023JSSCh.31823653L. doi:10.1016/j.jssc.2022.123653.
  108. ^ Lawton, Stephen L.; McAfee, Elwin Ray; Benson, James E.; Jacobson, Robert A. (December 1973). "Crystal structure of quinolinium hexabromoantimonate(V) tribromide, (C9H7NH)2SbVBr9". Inorganic Chemistry. 12 (12): 2939–2944. doi:10.1021/ic50130a040. ISSN 0020-1669.
  109. ^ Lawton, Stephen L.; Jacobson, Robert A. (April 1971). "Crystal structure of quinuclidinium dodecarbromoantimon(III)antimonate(V)-2-dibromine, (C7H13NH)4Sb(III)Sb(V)Br12.2Br2". Inorganic Chemistry. 10 (4): 709–712. doi:10.1021/ic50098a010. ISSN 0020-1669.
  110. ^ Taher, Marwa Ben; Chaari, Najla; Bechir, Mohamed Ben; Chaabouni, Slaheddine (April 2017). "X-ray diffraction, vibrational properties, and dielectric studies of 3-ammoniumpropyl imidazolium pentabromoantimonate (III)". Applied Physics A. 123 (4): 285. Bibcode:2017ApPhA.123..285T. doi:10.1007/s00339-017-0895-4. ISSN 0947-8396. S2CID 253852282.
  111. ^ Chang, Jen-Hui; Doert, Thomas; Ruck, Michael (2016-12-01). "(H 3 O) 3 Sb 2 Br 9 : the first member of the M 3 E 2 X 9 structure family with oxonium cations". Acta Crystallographica Section C Structural Chemistry. 72 (12): 966–970. doi:10.1107/S2053229616017198. ISSN 2053-2296. PMID 27918298.
  112. ^ Henke, H.; Kuhs, W. F. (1987-12-01). "The protonated water complex H 14 O 6 2+: A neutron diffraction study of HSbBr 6 · 3H 2 O". Zeitschrift für Kristallographie - Crystalline Materials. 181 (1–4): 113–126. doi:10.1524/zkri.1987.181.14.113. ISSN 2196-7105. S2CID 101332631.
  113. ^ Wojtaś, M.; Jakubas, R.; Ciunik, Z.; Medycki, W. (April 2004). "Structure and phase transitions in [(CH3)4P]3[Sb2Br9] and [(CH3)4P]3[Bi2Br9]". Journal of Solid State Chemistry. 177 (4–5): 1575–1584. Bibcode:2004JSSCh.177.1575W. doi:10.1016/j.jssc.2003.12.011.
  114. ^ Wojtaś, Maciej; Bil, Andrzej; Ga̧gor, Anna; Medycki, Wojciech; Kholkin, Andrei L. (2016). "Phase stability and dynamics of hybrid organic–inorganic crystals [(CH 3 ) 3 PH][SbCl 4 ] and [(CH 3 ) 3 PH][SbBr 4 ]: a computational and NMR approach". CrystEngComm. 18 (14): 2413–2424. doi:10.1039/C6CE00160B. ISSN 1466-8033.
  115. ^ a b Li, Bohan; Jin, Jiance; Yin, Meijuan; Zhang, Xinlei; Molokeev, Maxim S.; Xia, Zhiguo; Xu, Yan (2022-12-05). "Sequential and Reversible Phase Transformations in Zero-Dimensional Organic-Inorganic Hybrid Sb-based Halides towards Multiple Emissions". Angewandte Chemie International Edition. 61 (49): e202212741. doi:10.1002/anie.202212741. ISSN 1433-7851. PMID 36207278. S2CID 252758576.
  116. ^ Czado, Wolfgang; Müller, Ulrich (December 2002). "Crystal structure of tetraphenylphosphonium hexabromoantimonate(V), P(C6H5)4SbBr6". Zeitschrift für Kristallographie - New Crystal Structures. 217 (JG): 337–338. doi:10.1524/ncrs.2002.217.jg.337. ISSN 2197-4578. S2CID 98343578.
  117. ^ Fachbereich Biologie-Chemie, Universität Gh, D- Kassel, Wolfgang; Fachbereich Biologie-Chemie, Universität Gh, D- Kassel, Ulrich (1996-09-01). "Tetraphenylphosphonium-ikosioctabromooctaantimonat(III), (PPh 4 ) 4 Sb 8 Br 28 / Tetraphenylphosphonium Ikosioctabromooctaantimonate(III), (PPh 4 ) 4 Sb 8 Br 28". Zeitschrift für Naturforschung B. 51 (9): 1245–1247. doi:10.1515/znb-1996-0906. ISSN 1865-7117. S2CID 201092106.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  118. ^ a b Wei, Fengxia; Deng, Zeyu; Sun, Shijing; Hartono, Noor Titan Putri; Seng, Hwee Leng; Buonassisi, Tonio; Bristowe, Paul D.; Cheetham, Anthony K. (2019). "Enhanced visible light absorption for lead-free double perovskite Cs 2 AgSbBr 6". Chemical Communications. 55 (26): 3721–3724. doi:10.1039/C9CC01134J. ISSN 1359-7345. PMID 30869691. S2CID 76665497.
  119. ^ Wheeler, H. L. (1893-10-01). "On the double halides of antimony with rubidium". American Journal of Science. s3-46 (274): 269–279. Bibcode:1893AmJS...46..269W. doi:10.2475/ajs.s3-46.274.269. ISSN 0002-9599. S2CID 130685803.
  120. ^ a b Brik, Mikhail G.; Srivastava, Alok M. (2023-03-06). Luminescent Materials: Fundamentals and Applications. Walter de Gruyter GmbH & Co KG. p. 102. ISBN 978-3-11-060787-1.
  121. ^ Ephraim, Fritz; Weinberg, S. (November 1909). "Doppelhalogenide des drei-, vier- und fünfwertigen Antimons". Berichte der Deutschen Chemischen Gesellschaft. 42 (4): 4447–4456. doi:10.1002/cber.19090420441. ISSN 0365-9496.
  122. ^ Chang, Jen-Hui; Doert, Thomas; Ruck, Michael (2020-09-25). "The crystal structures of α -Rb 7 Sb 3 Br 16 , α - and β -Tl 7 Bi 3 Br 16 and their relationship to close packings of spheres". Zeitschrift für Kristallographie - Crystalline Materials. 235 (8–9): 255–261. doi:10.1515/zkri-2020-0013. ISSN 2196-7105. S2CID 222005314.
  123. ^ Mikhailov, Artem; Korobeynikov, Nikita; Usoltsev, Andrey; Adonin, Sergey A.; Kostin, Gennadiy A.; Schaniel, Dominik (2023). "Bismuth and antimony halometalates containing photoswitchable ruthenium nitrosyl complexes". Dalton Transactions. 52 (4): 919–927. doi:10.1039/D2DT03497B. ISSN 1477-9226. PMID 36594625. S2CID 254902411.
  124. ^ Ruan, Hang; Guo, Zhongnan; Lin, Jiawei; Liu, Kunjie; Guo, Lingling; Chen, Xin; Zhao, Jing; Liu, Quanlin; Yuan, Wenxia (2021-10-04). "Structure and Optical Properties of Hybrid-Layered-Double Perovskites (C 8 H 20 N 2 ) 2 AgMBr 8 (M = In, Sb, and Bi)". Inorganic Chemistry. 60 (19): 14629–14635. doi:10.1021/acs.inorgchem.1c01669. ISSN 0020-1669. PMID 34523334. S2CID 237514261.
  125. ^ Zhang, Jian; Yang, Ying; Deng, Hui; Farooq, Umar; Yang, Xiaokun; Khan, Jahangeer; Tang, Jiang; Song, Haisheng (2017-09-26). "High Quantum Yield Blue Emission from Lead-Free Inorganic Antimony Halide Perovskite Colloidal Quantum Dots". ACS Nano. 11 (9): 9294–9302. doi:10.1021/acsnano.7b04683. ISSN 1936-0851. PMID 28880532.
  126. ^ Combs, Victoria E.; Oswald, Iain W. H.; Neilson, James R. (2019-07-03). "Hydrothermal Crystal Growth of Mixed Valence Cs 2 SbBr 6". Crystal Growth & Design. 19 (7): 4090–4094. doi:10.1021/acs.cgd.9b00481. ISSN 1528-7483. S2CID 191147344.
Retrieved from "https://wiki.riteme.site/w/index.php?title=Bromoantimonates&oldid=1242821970"